Adverse event profiles of adjuvant treatment with opicapone in Parkinson's disease: A systematic review and meta-analysis

• Main Authors: Luwen Xie (Author), Xiaoyi Qi (Author), Xuan Wang (Author), Bing He (Author), Yu Wang (Author), Wei Zhang (Author), Zehui Yu (Author), Mingming Deng (Author), Sicheng Liang (Author), Muhan Lü (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Opicapone, a novel third-generation catechol-O-methyltransferase inhibitor, has demonstrated efficacy in Parkinson's Disease (PD) patients with end-of-dose motor fluctuations.Objective: This study aimed to compare the short-term (<6 months) and long-term (≥6 months) tolerability...